Aerosolization behavior of carrier-free l-leucine coated salbutamol sulphate powders

Janne Raula (Corresponding Author), Anna Lähde, Esko I. Kauppinen

Research output: Contribution to journalArticleScientificpeer-review

28 Citations (Scopus)

Abstract

Aerosolization behavior of carrier-free l-leucine coated salbutamol sulphate inhalable powders has been studied. l-Leucine coatings were formed by physical vapour deposition (PVD) on the surface of the spherical particles in the gas phase. While depositing l-leucine formed pointy crystalline asperities whose size and density increased with the increased content of l-leucine in the gas phase. The asperity size changed from few nanometers to hundreds of nanometers. Due to the rough surface, all these coated fine powders were well-flowable and could be fed without the aid of coarser carriers. The aerosolization characteristics of the powders were studied with ‘Inhalation Simulator’ under ascending and fast inhalation profiles. When detected on-line by infrared light attenuation, the emission of the coated powders from an inhaler (Easyhaler®) was distinctively dependent on the inhalation flow rate less than 30 l/min whereas that of micronized salbutamol sulphate powder solely depended on the studied inhalation flow rate range up to 100 l/min. Gravimetric measurements showed that emitted doses (ED) and fine particle fractions (FPF) of the coated powders were 5.1–7.1 mg/dose and 42–47%, respectively, which were 3–4 times higher than those of the micronized powder. The ED and FPF of the coated powders decreased as the surface roughness increased which is hypothesized as mechanical interlocking between the surface asperities.
Original languageEnglish
Pages (from-to)18-25
JournalInternational Journal of Pharmaceutics
Volume365
Issue number1 - 2
DOIs
Publication statusPublished - 2009
MoE publication typeA1 Journal article-refereed

Fingerprint

Albuterol
Leucine
Powders
Sulfates
Inhalation
Gases
Nebulizers and Vaporizers
Light

Keywords

  • aerosolization
  • coating
  • inhalation
  • l-leucine
  • surface roughness

Cite this

Raula, Janne ; Lähde, Anna ; Kauppinen, Esko I. / Aerosolization behavior of carrier-free l-leucine coated salbutamol sulphate powders. In: International Journal of Pharmaceutics. 2009 ; Vol. 365, No. 1 - 2. pp. 18-25.
@article{650ce1d2c19d4725a55d4628c60da823,
title = "Aerosolization behavior of carrier-free l-leucine coated salbutamol sulphate powders",
abstract = "Aerosolization behavior of carrier-free l-leucine coated salbutamol sulphate inhalable powders has been studied. l-Leucine coatings were formed by physical vapour deposition (PVD) on the surface of the spherical particles in the gas phase. While depositing l-leucine formed pointy crystalline asperities whose size and density increased with the increased content of l-leucine in the gas phase. The asperity size changed from few nanometers to hundreds of nanometers. Due to the rough surface, all these coated fine powders were well-flowable and could be fed without the aid of coarser carriers. The aerosolization characteristics of the powders were studied with ‘Inhalation Simulator’ under ascending and fast inhalation profiles. When detected on-line by infrared light attenuation, the emission of the coated powders from an inhaler (Easyhaler{\circledR}) was distinctively dependent on the inhalation flow rate less than 30 l/min whereas that of micronized salbutamol sulphate powder solely depended on the studied inhalation flow rate range up to 100 l/min. Gravimetric measurements showed that emitted doses (ED) and fine particle fractions (FPF) of the coated powders were 5.1–7.1 mg/dose and 42–47{\%}, respectively, which were 3–4 times higher than those of the micronized powder. The ED and FPF of the coated powders decreased as the surface roughness increased which is hypothesized as mechanical interlocking between the surface asperities.",
keywords = "aerosolization, coating, inhalation, l-leucine, surface roughness",
author = "Janne Raula and Anna L{\"a}hde and Kauppinen, {Esko I.}",
year = "2009",
doi = "10.1016/j.ijpharm.2008.08.017",
language = "English",
volume = "365",
pages = "18--25",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1 - 2",

}

Aerosolization behavior of carrier-free l-leucine coated salbutamol sulphate powders. / Raula, Janne (Corresponding Author); Lähde, Anna; Kauppinen, Esko I.

In: International Journal of Pharmaceutics, Vol. 365, No. 1 - 2, 2009, p. 18-25.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Aerosolization behavior of carrier-free l-leucine coated salbutamol sulphate powders

AU - Raula, Janne

AU - Lähde, Anna

AU - Kauppinen, Esko I.

PY - 2009

Y1 - 2009

N2 - Aerosolization behavior of carrier-free l-leucine coated salbutamol sulphate inhalable powders has been studied. l-Leucine coatings were formed by physical vapour deposition (PVD) on the surface of the spherical particles in the gas phase. While depositing l-leucine formed pointy crystalline asperities whose size and density increased with the increased content of l-leucine in the gas phase. The asperity size changed from few nanometers to hundreds of nanometers. Due to the rough surface, all these coated fine powders were well-flowable and could be fed without the aid of coarser carriers. The aerosolization characteristics of the powders were studied with ‘Inhalation Simulator’ under ascending and fast inhalation profiles. When detected on-line by infrared light attenuation, the emission of the coated powders from an inhaler (Easyhaler®) was distinctively dependent on the inhalation flow rate less than 30 l/min whereas that of micronized salbutamol sulphate powder solely depended on the studied inhalation flow rate range up to 100 l/min. Gravimetric measurements showed that emitted doses (ED) and fine particle fractions (FPF) of the coated powders were 5.1–7.1 mg/dose and 42–47%, respectively, which were 3–4 times higher than those of the micronized powder. The ED and FPF of the coated powders decreased as the surface roughness increased which is hypothesized as mechanical interlocking between the surface asperities.

AB - Aerosolization behavior of carrier-free l-leucine coated salbutamol sulphate inhalable powders has been studied. l-Leucine coatings were formed by physical vapour deposition (PVD) on the surface of the spherical particles in the gas phase. While depositing l-leucine formed pointy crystalline asperities whose size and density increased with the increased content of l-leucine in the gas phase. The asperity size changed from few nanometers to hundreds of nanometers. Due to the rough surface, all these coated fine powders were well-flowable and could be fed without the aid of coarser carriers. The aerosolization characteristics of the powders were studied with ‘Inhalation Simulator’ under ascending and fast inhalation profiles. When detected on-line by infrared light attenuation, the emission of the coated powders from an inhaler (Easyhaler®) was distinctively dependent on the inhalation flow rate less than 30 l/min whereas that of micronized salbutamol sulphate powder solely depended on the studied inhalation flow rate range up to 100 l/min. Gravimetric measurements showed that emitted doses (ED) and fine particle fractions (FPF) of the coated powders were 5.1–7.1 mg/dose and 42–47%, respectively, which were 3–4 times higher than those of the micronized powder. The ED and FPF of the coated powders decreased as the surface roughness increased which is hypothesized as mechanical interlocking between the surface asperities.

KW - aerosolization

KW - coating

KW - inhalation

KW - l-leucine

KW - surface roughness

U2 - 10.1016/j.ijpharm.2008.08.017

DO - 10.1016/j.ijpharm.2008.08.017

M3 - Article

VL - 365

SP - 18

EP - 25

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1 - 2

ER -